Keith R. Leonard, Jr.

Venture Partner at ARCH Venture Partners

Keith R. Leonard, Jr.

Keith R. Leonard, Jr.

Venture Partner at ARCH Venture Partners

Overview
Career Highlights

Unity Biotechnology, Inc.
Kythera Biopharmaceuticals LLC

RelSci Relationships

5301

Number of Boards

10

Birthday

1962

Age

58

Relationships
RelSci Relationships are individuals Keith R. Leonard, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder & President at Unity Biotechnology, Inc.

Relationship likelihood: Strong

Co-Founder at Vir Biotechnology, Inc.

Relationship likelihood: Strong

Managing Director at ARCH Venture Partners LP

Relationship likelihood: Strong

Founder & Co-Chairman at UCLA Venture Capital Fund (Venture Capital)

Relationship likelihood: Strong

Partner at Venrock Associates

Relationship likelihood: Strong

Owner & Chief Executive Officer at Fenton & Associates

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Chief Financial & Accounting Officer at Arcutis Biotherapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Sanifit Therapeutics SA

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Intuitive Surgical, Inc.

Relationship likelihood: Strong

Paths to Keith R. Leonard, Jr.
Potential Connections via
Relationship Science
You
Keith R. Leonard, Jr.
Venture Partner at ARCH Venture Partners
Education
M.B.A.
Class of 1995
MS in Engineering
Class of 1990
BA History
Class of 1987
B.S. in Engineering
Class of 1984
Career History
Co-Founder
2005 - 2015

Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA.

Senior Vice President & General Manager
1991 - 2004

Amgen Europe BV, part of Amgen, Inc., is a company headquartered in Breda, the Netherlands, that wholesales pharmaceutical products.

Senior Vice President & General Manager
1991 - 2004

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Boards & Committees
Member, Board of Directors
2016 - Current
Independent Director
2016 - Current
Chairman, Board of Directors
2016 - Current
Political Donations
Transactions
Details Hidden

Unity Biotechnology, Inc. raised money in a private placement transaction

Details Hidden

Unity Biotechnology, Inc. raised money in a private placement transaction

Details Hidden

Kythera Biopharmaceuticals LLC raised money in a private placement transaction

Investments
Details Hidden

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.

Details Hidden

Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Keith R. Leonard, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Keith R. Leonard, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Keith R. Leonard, Jr..